May 30, 2012
By:
Amy Ritter
Osiris Therapeutics announced that it received marketing authorization from Health Canada to market its stem cell therapy, Prochymal, for the treatment of graft-versus-host disease in children.
|
May 30, 2012
By:
Amy Ritter
Federal marshals seized an unapproved topical corticosteroid medication from California-based Crescendo Therapeutics.
|
May 16, 2012
By:
Amy Ritter
Senators Max Baucus (D-MT) and Chuck Grassley (R-IA) send letters to opioid manufacturers and pain groups asking them to disclose financial ties.
|
May 9, 2012
By:
Amy Ritter
Abbott Laboratories will pay $1.6 billion to settle outstanding issues concerning past sales and marketing practices for its neurologic medication, Depakote.
|
May 2, 2012
By:
Amy Ritter
At the request of FDA, the IOM prepared a report containing recommendations for how FDA might better monitor the safety of drugs after they have been approved.
|
|
In this technical forum, experts describe different methods of rapid microbial testing and their applications.
May 1, 2012
By:
Amy Ritter
In this technical forum, experts describe different methods of rapid microbial testing and their applications.
|
|
Readers share their views on bioprocessing challenges, equipment use, and outsourcing trends in our annual bioprocessing equipment and processing survey.
May 1, 2012
By:
Amy Ritter
Readers share their views on bioprocessing challenges, equipment use, and outsourcing trends in our annual bioprocessing equipment and processing survey.
|
Apr 11, 2012
By:
Amy Ritter
FDA has released a final guidance describing cGMP for preparing media fills for validation of aseptic preparations for positron emission tomography drugs.
|
Apr 5, 2012
By:
Amy Ritter
Ranbaxy Laboratories announced that beginning in March 2012, the first shipments of atorvastatin, the generic version of Pfizer's Lipitor, had been sent to US markets from its new Mohali manufacturing facility located in Punjab, India.
|
|
